SPAR HOSPITALSVEJ ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  3.4% 3.4% 3.4% 3.4% 3.4%  
Bankruptcy risk  2.0% 2.4% 8.2% 7.3% 8.1%  
Credit score (0-100)  70 64 28 33 29  
Credit rating  A BBB BB BBB BB  
Credit limit (kDKK)  0.5 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  2,634 3,057 2,309 2,567 2,374  
EBITDA  1,090 853 3.3 267 328  
EBIT  915 394 -615 -294 -311  
Pre-tax profit (PTP)  903.6 413.4 -617.8 -362.0 -465.9  
Net earnings  703.4 322.5 -482.1 -284.7 -417.6  
Pre-tax profit without non-rec. items  904 413 -618 -362 -466  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  1,183 2,957 2,812 2,316 1,795  
Shareholders equity total  2,335 1,908 1,426 1,141 723  
Interest-bearing liabilities  16.5 1,610 2,083 2,357 2,293  
Balance sheet total (assets)  4,492 5,552 5,237 5,333 4,895  

Net Debt  -786 1,463 1,448 1,444 1,332  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,634 3,057 2,309 2,567 2,374  
Gross profit growth  11.0% 16.1% -24.5% 11.2% -7.5%  
Employees  7 6 6 6 6  
Employee growth %  16.7% -14.3% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,492 5,552 5,237 5,333 4,895  
Balance sheet change%  25.4% 23.6% -5.7% 1.8% -8.2%  
Added value  1,089.9 853.4 3.3 324.3 327.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  548 1,314 -764 -1,057 -1,159  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 -1.0 -2.0 -3.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  34.7% 12.9% -26.6% -11.5% -13.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  23.1% 8.3% -11.0% -5.6% -6.1%  
ROI %  44.0% 14.0% -16.9% -8.2% -9.1%  
ROE %  35.5% 15.2% -28.9% -22.2% -44.8%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  52.0% 34.4% 27.2% 21.4% 14.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -72.2% 171.4% 44,159.6% 541.3% 406.1%  
Gearing %  0.7% 84.4% 146.1% 206.6% 316.9%  
Net interest  0 0 0 0 0  
Financing costs %  53.6% 0.4% 1.4% 3.1% 6.7%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.9 0.3 0.2 0.3 0.3  
Current Ratio  1.5 0.6 0.5 0.6 0.6  
Cash and cash equivalent  802.9 147.3 634.8 913.2 961.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  981.9 -1,275.4 -1,717.9 -1,514.9 -1,417.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  156 142 1 54 55  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  156 142 1 44 55  
EBIT / employee  131 66 -103 -49 -52  
Net earnings / employee  100 54 -80 -47 -70